26.11.2014 • News

Vencorex "Significantly Expanding" IPDI Capacity

Vencorex said it is "significantly expanding" its production capacity for isophorone diisocyanate (IPDI), the aliphatic isocyanate monomer used as feedstock for polyurethane resin, at its Pont de Claix, France, site.

CEO Magnus Lanner said the upgrade to 20,000 t/y by the end of 2016 will enhance Vencorex's capability to supply specialty areas while at the same time underlining the company's commitment to the isocyanates markets and further strengthening its position as one of the global leading suppliers.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read